<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03203538</url>
  </required_header>
  <id_info>
    <org_study_id>270755</org_study_id>
    <nct_id>NCT03203538</nct_id>
  </id_info>
  <brief_title>Light Intervention for Adaptation to Night Work</brief_title>
  <official_title>Effects of Bright Light Intervention for Adaptation to Night Work: Shift Work Simulation Experiments</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bergen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Glamox</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Bergen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The project will contribute with new knowledge concerning how aspects of the physical work
      environment (lighting conditions) can be arranged to facilitate the workers' adaptation to
      night work. This is important given the reported adverse consequences of shift work for
      performance, safety, and health. The project involves a series of three experimental,
      laboratory based shift work simulation studies. The aim is to investigate how different
      lighting conditions (intensities and colour temperature), administered through light emitting
      diode (LED) based bright light integrated standard room lighting, affects adaptation to three
      consecutive simulated night shifts and re adaptation to a day oriented schedule on measures
      of alertness, cognitive performance, sleep and circadian rhythm. The proposed project
      examines the effects of interventions that can be applied in naturalistic settings and will
      be based on new laboratory infrastructure available at the laboratories situated in the
      Faculty of Psychology, University of Bergen.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bright light has been suggested as a countermeasure to the negative impact of night work in
      terms of safety, performance and subsequent sleep. The effect depends on the timing of light
      (e.g, phase-response curve), duration of light exposure and the intensity of light, as well
      as the wavelengths that are emitted. Exposure to bright light (more intense than typical room
      lightning), at evening and night, has been effective in delaying the circadian rhythm to
      sufficiently adapt to night work both in simulated night work, and in field studies of
      workers. Blue light has significantly stronger phase shifting effects than other wavelengths
      of the visible spectrum. The effect of light on the circadian system is mediated by retinal
      photoresponsive cell population (intrinsically photoresponsive retinal ganglion cells; ipRGC)
      that contains the photopigment melanopsin, highly sensitive to blue light. These cells signal
      directly to the suprachiasmatic nuclei (SCN) of the hypothalamus, the circadian pacemaker.
      Bright light has also been reported to improve alertness and performance during night shifts.

      To the best of the investigators knowledge, no shift work simulation study has made the full
      advance of LED-technology in terms of using light administered via standard room lighting on
      adaptation to night work. Today, new LED-technology represents an excellent opportunity to
      study this as roof mounted LED-sources integrated as standard indoor lightening can be
      programmed to provide a wide range of light intensities and colour temperatures. LED-sources
      have the advantage over standard light therapy that subjects can be exposed to the therapy
      via standard room lightening (not confined to a special therapy lamp) thereby allowing the
      workers to conduct work tasks as normal during light exposure.

      Against this backdrop this project aims to investigate how different lighting conditions,
      administered through LED-based bright light integrated standard room lighting, affects
      adaptation to three consecutive simulated night shifts and re adaptation to a day oriented
      schedule on measures of alertness, cognitive performance, sleep and circadian rhythm. In
      addition, measures of mood, appetite, heart rate variability (HRV), pain sensitivity, moral
      reasoning, and inflammatory markers will be examined. The researchers also aim to investigate
      the effects of two extreme monochromatic light conditions (blue vs. red) based on integrated
      standard room lighting on the adaptation to one simulated night shift.

      Study participants will work simulated night shifts (11:00 pm to 07:00 am) in a light
      laboratory where light parameters (intensity and colour temperature) can be manipulated via
      roof mounted LED-sources integrated as standard indoor lightening. Participants will be
      recruited among students at the University of Bergen, and a screening will be done to ensure
      healthy participants fit for the study. The included participants will take part in
      experiments with two bouts of three consecutive simulated night shifts (6 nights in total).

      HRV will be measured throughout the night shift, and five times, approx. every 1.5 hour
      (11:30 pm, 01:00 am, 02:30 am, 04:00 am, 05:30 am), the subjects will be tested on a test
      battery of cognitive tests and will rate their subjective sleepiness. Sleep will be assessed
      by sleep diary and actigraphy 3 days prior to, during, and 3 days following the shifts. One
      day before the night shift and the day after the night shift period the circadian rhythm will
      be measured by saliva samples for estimation of dim light melatonin onset. Prior to-, during-
      and after the night shifts, participants will undergo a pain sensitivity test. Blood spot
      samples will be collected at the beginning and the end of each night shift for analysis of
      inflammatory markers (e.g. interleukins).
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">August 25, 2017</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Three related night shift studies have been planned. Each study investigates how different lighting conditions, administered through LED-based bright light integrated standard room lighting, affects adaptation to simulated night shifts and re adaptation to a day oriented schedule.
In each study, 28 participants (84 in total) will be exposed to the interventions (light conditions) in a randomized, blinded, controlled, crossover study.
The simulated night shifts will last from 11pm to 7am. The specific light conditions will last from 11pm to 5am (study 1: 1000 lux vs. 100 lux; study 2: 7000 K vs. 2500 K; study 3: 455 nm vs. 615 nm) where after (from 5am to 7am) all participants will be exposed to the same light conditions (200 lux, 4000 K). After completion of one bout of night work (three consecutive shifts for study 1 and 2; one night shift for study 3) there will be a washout period of four weeks before the participants cross over.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Participants will not be given information on the hypotheses/ expected effects from the different interventions (light conditions).</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Cognitive performance</measure>
    <time_frame>3 nights</time_frame>
    <description>Cognitive performance will be measured using the Psychomotor Vigilance Test (PVT). The PVT measures sustained attention, and is considered the 'gold standard' for assessing the effects of sleep deprivation on cognition. The task will be performed approx. every 1.5h throughout the nightshifts.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Circadian phase</measure>
    <time_frame>5 days-nights</time_frame>
    <description>Circadian phase will be measured through assessement of 'Dim Light Melatonin Onset' (DLMO). Saliva samples will be collected every hour in the evening (from 7 pm) to one hour past regular bedtime, one day before the first night shift and the day after the night shift period. Saliva will be analyzed for melatonin, giving an estimate on DLMO.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sleep</measure>
    <time_frame>9 days-nights</time_frame>
    <description>Sleep will be measured objectively using actigraphy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjective sleepiness</measure>
    <time_frame>3 nights</time_frame>
    <description>Karolinska Sleepiness Scale (KSS) will be used to assess subjective sleepiness throughout the night shifts. KSS is a likert scale ranging from 1-9, where subjects rate their sleepiness. '1' indicates 'extremely alert', '9' indicates 'very sleepy/fighting sleep'.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported sleep</measure>
    <time_frame>9 days-nights</time_frame>
    <description>A sleep diary will be used.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate variability</measure>
    <time_frame>3 nights</time_frame>
    <description>'Heart Rate Variability' will be assessed by using Polar heart rate monitor V800 that will continuously monitor 'HRV' through the night.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin</measure>
    <time_frame>3 nights</time_frame>
    <description>Blood spot samples will be analyzed for interleukins (IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-13)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Granulocyte macrophage colony-stimulating factor (GM-CSF)</measure>
    <time_frame>3 nights</time_frame>
    <description>Blood-spot samples will be analyzed for GM-CSF.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interferon gamma (IFN-gamma)</measure>
    <time_frame>3 nights</time_frame>
    <description>Blood-spot samples will be analyzed for IFN-gamma.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tumor necrosis factor alpha (TNF-a)</measure>
    <time_frame>3 nights</time_frame>
    <description>Blood-spot samples will be analyzed for TNF-a</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive and negative affect</measure>
    <time_frame>3 nights</time_frame>
    <description>'Positive and Negative Affect Schedule', will be administered to assess mood.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain sensitivity</measure>
    <time_frame>3 nights</time_frame>
    <description>By using a handheld pressure algometer, Wagner FPIX Force One, the pressure pain threshold will be measured. The test site will be the trapezius muscle, and the pressure will be increased in steps of 5 N/sec until the participant indicates pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Headache and eyestrain</measure>
    <time_frame>3 nights</time_frame>
    <description>A 'Headache and Eyestrain Scale' will be used to get subjective measures on how participants perceive the lighting conditions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Appetite/ food cravings</measure>
    <time_frame>3 nights</time_frame>
    <description>Appetite/ food cravings for different food types will be assessed using a visual analogue scale to record response to questions like: &quot;How much would you like to eat xxx right now?&quot;
A 'Dot-probe test' provides measure of attentional bias towards various food types (pictures)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Working memory</measure>
    <time_frame>3 nights</time_frame>
    <description>A 'Working Memory Scanning Task' measure ability to encode and maintain information in working memory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decision/ response execution</measure>
    <time_frame>3 nights</time_frame>
    <description>A 'Two-Choice Numerosity Discrimination Task' measure decision criterion and response execution</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decision/ response inhibition</measure>
    <time_frame>3 nights</time_frame>
    <description>A 'Reversal Learning Decision Task' measure ability to adjust choices/ response inhibition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive control</measure>
    <time_frame>3 nights</time_frame>
    <description>A 'Task Switching-Performance Test' measure cognitive control</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Planning</measure>
    <time_frame>3 nights</time_frame>
    <description>The 'Tower of Hanoi Test' measure planning and sequencing abilities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Moral reasoning</measure>
    <time_frame>3 nights</time_frame>
    <description>the 'Defining Issues Test' measure moral reasoning.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive throughput</measure>
    <time_frame>3 nights</time_frame>
    <description>A 'Digit Symbol Substitution Test' will be used as a measure of cognitive throughput</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fine motor skills</measure>
    <time_frame>3 nights</time_frame>
    <description>The 'grooved pegboard test' assess fine motor skills through the night shifts</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recognition of emotions</measure>
    <time_frame>3 nights</time_frame>
    <description>An 'emotional hexagon test', were participants rate standardized pictures of faces expressing different emotions, measure the ability to discriminate between emotional expressions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pupil size</measure>
    <time_frame>3 nights</time_frame>
    <description>Pupil size will be measured, using a tobii eyetracker, three times during night shifts. This can provide an objective measure of sleepiness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Core body temperature</measure>
    <time_frame>1-2 nights</time_frame>
    <description>To get a secondary measure of circadian phase, core body temperature will be measured using ingestible temperature capsules.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Leadership evaluation</measure>
    <time_frame>2 nights, 1 day</time_frame>
    <description>The 'Multifactor Leadership Questionnaire' will be used to assess participants leadership preferences. The questionnaire will be administered during daytime and during night shifts.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Experiences of perceptual anomalies</measure>
    <time_frame>3 nights</time_frame>
    <description>The Cardiff Anomalous Perceptions Scale (CAPS) questionnaire will be administered after the night shifts to assess experiences of hallucinations and perceptual anomalies during night shifts. The questionnaire consists of 32 items/questions regarding perceptual anomalies, e.g. &quot;Do you ever notice that sounds are much louder than they normally would be?&quot;, that are answered with 'yes' or 'no'. Adding up the number of 'yes' answers gives the CAPS Total Score ranging from 0 (low) to 32 (high). For each item endorsed, participants rate the item for distress, intrusiveness and frequency, giving three subscales. The rating for subscales goes from 1 (low) to 5 (high). Nonendorsed items are considered to have a score of 0 on subscales. For each subscale the possible range goes from 0 (low) to 160 (high).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Objective sleepiness, sleep and sleep stages</measure>
    <time_frame>3 nights and sleep periods</time_frame>
    <description>A subgroup of participants (12-16 in each experiment) will be subject to electroencephalography (EEG) during night shifts, and polysomnography (PSG) after night shifts. EEG will provide a measure of electrical activity in the brain during wakefulness, and can provide an objective measure of sleepiness. PSG will be conducted in the sleep period after night shifts, and allow for the scoring of sleep stages. PSG is considered the gold standard for measuring sleep.</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Shift-Work Related Sleep Disturbance</condition>
  <condition>Sleep Deprivation</condition>
  <condition>Sleep</condition>
  <arm_group>
    <arm_group_label>Light intensity, 1000 lux (4000 K)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will work three consecutive simulated night shifts under full-spectrum LED-light, 1000 lux (4000 Kelvin) administered through standard room lighting.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Light intensity, 100 lux (4000 K)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will work three consecutive simulated night shifts under full-spectrum LED-light, 100 lux (4000 Kelvin) administered through standard room lighting.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Colour temperature, 7000 Kelvin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will work three consecutive simulated night shifts under full-spectrum LED-light, 7000 K (200 lux) administered through standard room lighting.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Colour temperature, 2500 Kelvin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will work three consecutive simulated night shifts under full-spectrum LED-light, 2500 K (200 lux) administered through standard room lighting.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Blue light, 455 nm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants work one night shift with blue LED-light (peak wavelength 455 nm) administered through standard room lighting.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Red light, 615 nm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants work one night shift with red LED-light (peak wavelength 615 nm) administered through standard room lighting.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LED-light, 1000 lux</intervention_name>
    <description>Full-spectrum light, 1000 lux, 4000 K. Represent a light intensity within acceptable range (light that is not too glary); 4000 K is among the most commonly used indoor light colour temperatures.</description>
    <arm_group_label>Light intensity, 1000 lux (4000 K)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LED-light, 100 lux</intervention_name>
    <description>Full-spectrum light, 100 lux, 4000 K. Represent a light intensity within acceptable range (light that provides sufficient eye sight); 4000 K is among the most commonly used indoor light colour temperatures.</description>
    <arm_group_label>Light intensity, 100 lux (4000 K)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LED-light, 7000 K</intervention_name>
    <description>Full-spectrum light, 7000 K, 200 lux. Represent the upper border of common colour indoor light temperature, 200 lux is a common indoor light intensity.</description>
    <arm_group_label>Colour temperature, 7000 Kelvin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LED-light, 2500 K</intervention_name>
    <description>Full-spectrum light, 2500 K, 200 lux. Represent the lower border of common colour indoor light temperature, 200 lux is a common indoor light intensity.</description>
    <arm_group_label>Colour temperature, 2500 Kelvin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Blue LED-light</intervention_name>
    <description>Blue light with peak wavelength 455 nm. Known to delay the circadian rhythm, suppress melatonin, and increase alertness.</description>
    <arm_group_label>Blue light, 455 nm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Red LED-light</intervention_name>
    <description>Red light with peak wavelength 615 nm. Known not to affect the circadian rhythm, melatonin, and alertness.</description>
    <arm_group_label>Red light, 615 nm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants are physical and mentally healthy (assessed with BMI and 'General Health
             Questionnaire-12')

          -  Participants accept to comply with the protocol (refrain from alcohol, tobacco and
             coffee, and retain regular bed- and wake-times the week before the simulated night
             shifts)

        Exclusion Criteria:

          -  Neurological, psychiatric or sleep related disorders ('Bergen Insomnia Scale', 'global
             sleep assessement questionnaire')

          -  Extreme 'morningness-eveningness' type ('Horne Ã–stberg morningness eveningness
             questionnaire')

          -  Use of medication

          -  Worked night shifts the last 3 months

          -  Travelled through more than two time zones the last 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erlend Sunde</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bergen, department of psychosocial science</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The faculty of psychology, University of Bergen</name>
      <address>
        <city>Bergen</city>
        <state>Hordaland</state>
        <zip>5020</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2017</study_first_submitted>
  <study_first_submitted_qc>June 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 29, 2017</study_first_posted>
  <last_update_submitted>February 13, 2018</last_update_submitted>
  <last_update_submitted_qc>February 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>night work</keyword>
  <keyword>shift work</keyword>
  <keyword>light</keyword>
  <keyword>bright light</keyword>
  <keyword>sleep</keyword>
  <keyword>cognitive performance</keyword>
  <keyword>circadian rhythm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyssomnias</mesh_term>
    <mesh_term>Sleep Wake Disorders</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
    <mesh_term>Sleep Deprivation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>After the project has ended the data will be anonymized and no direct recognizable information will be stored.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

